Nootropics
Evidence: animal_plus_anecdotal
Structural analog of choline that crosses the BBB more readily than choline itself. Paradoxically increases choline availability not by serving as a direct precursor to acetylcholine, but by inhibiting choline metabolism in peripheral tissues, thereby increasing circulating choline available for brain uptake. Also acts as a free radical scavenger and membrane stabilizer. Reduces lipofuscin accumulation in neuronal cells, an age pigment associated with cellular aging.
Standard: 150-400 mg/day (as DMAE bitartrate, typically 37% DMAE)
Maintenance: 150-300 mg/day
Administration: oral
Timing: Morning. With or without food.
Duration: Ongoing; no strict cycling required
Weaker nootropic than Alpha-GPC or CDP-Choline. The claim that DMAE is a direct acetylcholine precursor is incorrect — its mechanism is indirect. Primary appeal is as an anti-aging compound (lipofuscin reduction) rather than acute cognitive enhancer. Contraindicated in pregnancy based on animal data showing neural tube defects. The vivid dreams effect is commonly reported and some users find it beneficial.
Available as DMAE bitartrate (most common) or DMAE pidolinate. Bitartrate salt contains ~37% free DMAE. Widely available from supplement manufacturers. Quality varies — source from GMP-certified facilities.
Take the free assessment and get personalized recommendations based on your biology and goals.
Get Your Free Protocolor take the assessment →